New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
07:18 EDTMDTMedtronic CoreValve data positive, says Oppenheimer
After data from Medtronic's CoreValve high-risk transcatheter valve was released, Oppenheimer thinks the data met high expectations. The firm expects the CoreValve rollout to be strong. It raised its price target on the stock to $67 from $65 and keeps an Outperform rating on the shares.
News For MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 11, 2014
09:05 EDTMDTMedtronic receives FDA approval for Attain Performa LV quadripolar leads
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use